Want to see INDOY full AI Analyst Report?
Top Page
Indorama Ventures
(OTC:INDOY)
Select Model
Select Model
Rating:51Neutral
Price Target:
$9.00
â–²(32.74% Upside)
Action:Reiterated
Date:09/10/26
The score is driven primarily by mixed financial performance: improving operations and strong free-cash-flow momentum are tempered by persistent net losses and high leverage. Technicals are supportive with the stock trading above major moving averages and positive MACD, but overbought readings (RSI/Stochastics) add near-term risk. Valuation remains pressured by the negative P/E, with the dividend yield offering only modest support.
Positive Factors
Integrated global value chain
An integrated value chain allows Indorama Ventures to participate across several production stages, capture margin at multiple points, and reduce reliance on a single product. Its global footprint and diversified end markets can also help balance regional demand cycles over the next several quarters.
Negative Factors
Persistent net losses
Continuing net losses show that the improvement in operating profitability has not yet translated into sustainable bottom-line earnings. This weakens retained capital generation and signals that earnings remain volatile, leaving the recovery incomplete over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Integrated global value chain
An integrated value chain allows Indorama Ventures to participate across several production stages, capture margin at multiple points, and reduce reliance on a single product. Its global footprint and diversified end markets can also help balance regional demand cycles over the next several quarters.
Read all positive factors
Indorama Ventures (INDOY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$4.79B
Dividend Yield2.86%
Average Volume (3M)26.00
Price to Earnings (P/E)―
Beta (1Y)0.25
Revenue Growth-2.67%
EPS Growth-538.98%
CountryUS
Employees22,027
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)-5.70
Shares Outstanding561,455,200
10 Day Avg. Volume0
30 Day Avg. Volume26
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)0.87
Price to Sales (P/S)0.21
P/FCF Ratio5.79
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Indorama Ventures Business Overview & Revenue Model
Company Description
Indorama Ventures Public Company Limited functions as a global manufacturer and distributor of a wide array of chemical and fiber products. Its extensive product range includes polyethylene terephthalate (PET), purified terephthalic acid (PTA), pa...
How the Company Makes Money
Indorama Ventures primarily makes money by manufacturing and selling petrochemical and polymer products across an integrated chain, with earnings largely tied to sales volumes and commodity-linked margins (spreads) between feedstocks and finished ...
Indorama Ventures Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
40
Negative
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 460.97B | 428.76B | 541.58B | 544.30B | 656.27B | 470.55B |
| Gross Profit | 60.15B | 47.78B | 75.26B | 68.26B | 114.04B | 84.98B |
| EBITDA | 36.87B | 23.43B | 22.18B | 29.47B | 76.32B | 63.81B |
| Net Income | -2.25B | -7.35B | -19.26B | -10.80B | 31.01B | 26.29B |
Balance Sheet | ||||||
| Total Assets | 566.86B | 523.73B | 541.55B | 590.13B | 623.88B | 541.83B |
| Cash, Cash Equivalents and Short-Term Investments | 39.04B | 28.00B | 19.08B | 20.79B | 23.06B | 16.46B |
| Total Debt | 280.59B | 279.16B | 262.02B | 254.33B | 254.31B | 224.23B |
| Total Liabilities | 436.76B | 409.62B | 402.62B | 412.06B | 422.99B | 370.82B |
| Stockholders Equity | 117.54B | 102.68B | 125.95B | 164.36B | 185.99B | 158.77B |
Cash Flow | ||||||
| Free Cash Flow | 32.13B | 15.49B | 17.52B | 26.90B | 49.42B | 10.57B |
| Operating Cash Flow | 47.82B | 32.64B | 35.11B | 53.13B | 77.98B | 33.77B |
| Investing Cash Flow | -16.28B | -25.55B | -21.88B | -25.65B | -74.16B | -25.77B |
| Financing Cash Flow | -13.74B | 2.52B | -14.54B | -28.91B | 1.52B | -10.89B |
Indorama Ventures Technical Analysis
Positive
6.78
Price Trends
7.41
Positive
7.23
Positive
6.83
Positive
Market Momentum
0.43
Positive
61.57
Neutral
18.92
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For INDOY, the sentiment is Positive. The current price of 6.78 is below the 20-day moving average (MA) of 8.34, below the 50-day MA of 7.41, and below the 200-day MA of 6.83, indicating a bullish trend. The MACD of 0.43 indicates Positive momentum. The RSI at 61.57 is Neutral, neither overbought nor oversold. The STOCH value of 18.92 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for INDOY.
Indorama Ventures Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $9.06B | 12.27 | 7.73% | 8.55% | 17.90% | 95.98% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | $20.24B | -15.52 | -6.58% | 5.00% | -1.20% | -30.03% | |
56 Neutral | $5.17B | -4.41 | -28.81% | 0.25% | -2.28% | 27.94% | |
51 Neutral | $4.79B | -48.31 | -2.07% | 2.86% | -2.67% | -538.98% | |
49 Neutral | $1.56B | -8.95 | -6.28% | 3.93% | 0.65% | 45.36% | |
42 Neutral | $617.51M | -0.69 | 142.56% | 18.42% | -1.40% | 2.39% |
* Basic Materials Sector Average
INDOY
Indorama Ventures
8.54
1.76
26.00%
CE
Celanese
47.09
6.35
15.58%
BAK
Braskem SA
1.54
-0.93
-37.65%
HUN
Huntsman
8.90
0.29
3.42%
SSL
Sasol
14.03
7.82
125.93%
DOW
Dow Inc
28.02
6.21
28.46%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.